The threat of multi-resistant germs and bacteria has been widely covered in the media. Companies like BioVersys in Basel are researching new methods to treat infections – in this case not by developing a new antibiotic but a method to restore the effectiveness of existing medications. Bacteria have survived over centuries because they have the unique ability to adapt to new circumstances through spontaneous mutation or by DNA transfer. Some have attained multi-drug resistance, rendering current successful antibiotics ineffective. This proves to be a huge healthcare burden.